EUVIMEDEUVIMED entdecken
Open Access

Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2

Zhaojun Duan, Zhen Li, Ziyuan Wang, Chong Chen, Yunping Luo

Cancer Immunology, Immunotherapy · 2023-10 · 72 (10) · 3243-3257

DOI: 10.1007/s00262-023-03490-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 12.07.2023. Verfasst von Zhaojun Duan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical Co…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Funds for the Central Universities, Bilateral Inter-Governmental S&T Cooperation Project from Ministry of Science and Technology of China, The Prospective Research Program of the Foundation for the Development of Frontier Technology of Cell Therapy of Changzhou Xitaihu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenNeoplasmsMiceAnimalsToll-Like Receptor 4Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AMacrophagesImmunotherapy, AdoptiveTumor Microenvironment

Stichwörter der Autor:innen

Breast cancerCAR-MIfngr1Ifngr2Tlr4VEGFR2

Substanzen

Receptors, Chimeric AntigenToll-Like Receptor 4Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
  • Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China. ypluo@ibms.pumc.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Bilateral Inter-Governmental S&T Cooperation Project from Ministry of Science and Technology of China
  • The Prospective Research Program of the Foundation for the Development of Frontier Technology of Cell Therapy of Changzhou Xitaihu

Zitieren

APA

Duan, Z., Li, Z., Wang, Z., Chen, C., & Luo, Y. (2023). Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2. Cancer Immunology, Immunotherapy, 72(10), 3243-3257. https://doi.org/10.1007/s00262-023-03490-8

Vancouver

Duan Z, Li Z, Wang Z, Chen C, Luo Y. Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2. Cancer Immunology, Immunotherapy. 2023;72(10):3243-3257. doi:10.1007/s00262-023-03490-8

BibTeX
@article{Duan2023,
  author = {Duan, Zhaojun and Li, Zhen and Wang, Ziyuan and Chen, Chong and Luo, Yunping},
  title = {Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2023},
  volume = {72},
  number = {10},
  pages = {3243--3257},
  doi = {10.1007/s00262-023-03490-8}
}
Kostenlos starten →